Shareholder Notification

For filings with the FSA include the annex For filings with issuer exclude the annex TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi 1. Identity of the issuer or the underlying Bioventix plc issuer of existing shares to which voting rights are attached: ii 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights YES An acquisition or disposal of qualifying financial instruments which NO may result in the acquisition of shares already issued to which voting rights are attached An acquisition or disposal of instruments with similar economic effect NO to qualifying financial instruments An event changing the breakdown of voting rights NO Other (please NO specify): 3. Full name of person(s) subject to MAM Funds plc the notification obligation: iii 4. Full name of shareholder(s) (if See Section 9 below different from 3.):iv 5. Date of the transaction and date 17/12/2012 on which the threshold is crossed or reached: v 6. Date on which issuer notified: 18/12/2012 7. Threshold(s) that is/are crossed Was 20.80%, Now 22.69% or reached: vi, vii 8. Notified details: A: Voting rights attached to shares viii, ix Class/type of Situation previous Resulting situation after shares to the triggering the triggering transaction transaction if possible Number Number % of voting using Number of Number of rights x the ISIN CODE of Voting of voting Shares Rights shares rights Direct Direct Indirect Direct Indirect xi xii GB00B4QVDF07 1,045,000 1,045,000 1,140,000 n/a 1,140,000 n/a 22.69% B: Qualifying Financial Instruments Resulting situation after the triggering transaction Type of financial Expiration Exercise/ Number of voting % of voting instrument date xiii Conversion Period rights that may be rights xiv acquired if the instrument is exercised/ converted. n/a n/a n/a n/a n/a C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi Resulting situation after the triggering transaction Type of Exercise Expiration Exercise/ Number of voting % of voting financial price date xvii Conversion rights instrument rights xix, xx instrument period refers to xviii Nominal Delta Total (A+B+C) Number of voting rights Percentage of voting rights 1,140,000 22.69% 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi Diverse Income Trust HSBC Global Custody Nominee (UK) Ltd a/c 727563 720,397 Milton UK Multicap Income Fund Bank of New York Nominees Ltd a/c 397449 324,603 CF Miton UK Smaller Companies Fund BNY Custodial Nominees (Ireland) Limited a/c 397904 95,000 Proxy Voting: 10. Name of the proxy holder: n/a 11. Number of voting rights proxy n/a holder will cease to hold: 12. Date on which proxy holder will n/a cease to hold voting rights: 13. Additional information: Midas Capital Partners Ltd and Miton Asset Management Ltd are both subsidiaries of MAM Funds plc 14. Contact name: John Bradley 15. Contact telephone number: 0151 906 2462 Note: Annex should only be submitted to the FSA not the issuer Annex: Notification of major interests in sharesxxii A: Identity of the persons or legal entity subject to the notification obligation Full name (including legal form of legal entities) Contact address (registered office for legal entities) Phone number & email Other useful information (at least legal representative for legal persons) B: Identity of the notifier, if applicable Full name Contact address Phone number & email Other useful information(e.g. functional relationship with the person or legal entity subject to the notification obligation) C: Additional information For notes on how to complete form TR-1 please see the FSA website.

Companies

Bioventix (BVXP)
UK 100

Latest directors dealings